Jump to content

Expert Review of Anticancer Therapy

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 2a00:23c8:5c06:5e01:30c4:5166:49db:6beb (talk) at 14:41, 13 September 2021. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Expert Review of Anticancer Therapy
DisciplineOncology
LanguageEnglish
Edited byRona Williamson
Publication details
History2001-present
Publisher
FrequencyMonthly
4.512 (2020)
Standard abbreviations
ISO 4Expert Rev. Anticancer Ther.
Indexing
CODENERATBJ
ISSN1473-7140 (print)
1744-8328 (web)
OCLC no.60638399
Links

Expert Review of Anticancer Therapy is a monthly peer-reviewed medical journal covering all clinical aspects of cancer therapy. It was established in 2001 and is published by Taylor & Francis under the academic publishing division of Informa. The current Editor-in-Chief is Gertjan J L Kaspers who is Head of Pediatric Oncology at VU University Medical Center Amsterdam. According to Journal Citation Reports, the journal has a 2020 impact factor of 4.512 and a 2020 CiteScore of 6.4.[1]

References

  1. ^ "Expert Review of Anticancer Therapy". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.